欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3324/002
药品名称Pemetrexed Alvogen 500 mg
活性成分
    • PEMETREXED DISODIUM 25.0 mg/ml
剂型Powder for concentrate for solution for infusion
上市许可持有人Alvogen IPCo S.àr.l. 5, Rue Heienhaff, Senningerberg L-1736 Luxembourg
参考成员国 - 产品名称Netherlands (NL)
Pemetrexed Alvogen 500 mg poeder voor concentraat voor oplossing voor intraveneuze infusie
互认成员国 - 产品名称
    • Latvia (LV)
      Pemetrexed Zentiva 500 mg pulveris infūziju šķīduma koncentrāta pagatavošanai
    • Bulgaria (BG)
    • Lithuania (LT)
      Pemetrexed Alvogen 500 mg milteliai infuzinio tirpalo koncentratui
    • Estonia (EE)
      PEMETREXED ALVOGEN
许可日期2015/10/22
最近更新日期2023/03/15
药物ATC编码
    • L01BA04 pemetrexed
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase